Alpha 2.0
Login Register
» Articles » PMID: 3040664

Diversity of Chlamydia Trachomatis Major Outer Membrane Protein Genes

Overview
Journal J Bacteriol
Publisher American Society for Microbiology
Specialty Microbiology
Date 1987 Sep 1
PMID 3040664
Citations 118
Authors
R S Stephens
E A Wagar
C Inouye
M S Urdea
Affiliations
Soon will be listed here.
Abstract

Genomic DNA libraries were constructed for Chlamydia trachomatis serovars B and C by using BamHI fragments, and recombinants that contained the major outer membrane protein (omp1) gene for each serovar were identified and sequenced. Comparisons between these gene sequences and the gene from serovar L2 demonstrated fewer base pair differences between serovars L2 and B than between L2 and C; this finding is consistent with the serologic and antigenic relationships among these serovars. The translated amino acid sequence for the major outer membrane proteins (MOMPs) contained the same number of amino acids for serovars L2 and B, whereas the serovar C MOMP contained three additional amino acids. The antigenic diversity of the chlamydial MOMP was reflected in four sequence-variable domains, and two of these domains were candidates for the putative type-specific antigenic determinant. The molecular basis of omp1 gene diversity among C. trachomatis serovars was observed to be clustered nucleotide substitutions for closely related serovars and insertions or deletions for distantly related serovars.

Citing Articles

Sequence, structure prediction, and epitope analysis of the polymorphic membrane protein family in Chlamydia trachomatis.

Cervantes P, Segelke B, Lau E, Robinson B, Abisoye-Ogunniyan A, Pal S PLoS One. 2024; 19(6):e0304525.

PMID: 38861498 PMC: 11166332. DOI: 10.1371/journal.pone.0304525.

Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG.

Slepenkin A, Pal S, Rasley A, Coleman M, de la Maza L NPJ Vaccines. 2024; 9(1):104.

PMID: 38858418 PMC: 11164897. DOI: 10.1038/s41541-024-00880-6.

Determination of the safety and efficacy of recombinant Chlamydia muridarum MOMP vaccines, formulated with CpG-1826 and 70%, 50%, 30% or 10% concentrations of Montanide ISA-720 VG, to elicit protective immune responses against a C. muridarum....

de la Maza L, Slepenkin A, Pal S, Rasley A, Coleman M Res Sq. 2024; .

PMID: 38168233 PMC: 10760204. DOI: 10.21203/rs.3.rs-3688658/v1.

-An Emerging Old Entity?.

Grygiel-Gorniak B, Folga B Microorganisms. 2023; 11(5).

PMID: 37317257 PMC: 10221348. DOI: 10.3390/microorganisms11051283.

The Polymorphic Membrane Protein G Has a Neutral Effect and the Plasmid Glycoprotein 3 an Antagonistic Effect on the Ability of the Major Outer Membrane Protein to Elicit Protective Immune Responses against a Respiratory Challenge.

Slepenkin A, Pal S, Hoang-Phou S, Abisoye-Ogunniyan A, Rasley A, Dhaeseleer P Vaccines (Basel). 2023; 11(3).

PMID: 36992088 PMC: 10051784. DOI: 10.3390/vaccines11030504.

References
1.
Shine J, Dalgarno L . The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites. Proc Natl Acad Sci U S A. 1974; 71(4):1342-6. PMC: 388224. DOI: 10.1073/pnas.71.4.1342. View
2.
GRAYSTON J, Wang S . New knowledge of chlamydiae and the diseases they cause. J Infect Dis. 1975; 132(1):87-105. DOI: 10.1093/infdis/132.1.87. View
3.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View
4.
Chen R, Kramer C, Schmidmayr W, Henning U . Primary structure of major outer membrane protein I of Escherichia coli B/r. Proc Natl Acad Sci U S A. 1979; 76(10):5014-7. PMC: 413069. DOI: 10.1073/pnas.76.10.5014. View
5.
Karn J, Brenner S, Barnett L, Cesareni G . Novel bacteriophage lambda cloning vector. Proc Natl Acad Sci U S A. 1980; 77(9):5172-6. PMC: 350019. DOI: 10.1073/pnas.77.9.5172. View